Literature DB >> 12140612

Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.

Kazuhiro Hirohashi1, Takahiro Uenishi, Shoji Kubo, Takatsugu Yamamoto, Hiromu Tanaka, Taichi Shuto, Osamu Yamasaki, Katsuhiko Horii, Hiroaki Kinoshita.   

Abstract

BACKGROUND/
PURPOSE: Although curative surgical resection provides the best chance of long-term survival for patients with intrahepatic cholangiocarcinoma, the presence of bile duct invasion decreases postoperative survival rates in patients with mass-forming intrahepatic cholangiocarcinoma. We carried out this study to determine a surgical strategy for patients with bile duct invasion of these tumors.
METHODS: Forty-one patients with mass-forming intrahepatic cholangiocarcinoma were classified as either having bile duct invasion ( n = 26) or not having bile duct invasion ( n = 15). Clinicopathologic findings, including postoperative outcomes, were compared between these two groups.
RESULTS: Perineural invasion, lymphatic invasion, and a positive resection margin were more frequent in patients with ductal invasion. Patients with ductal invasion had lower survival rates than those without ductal invasion.
CONCLUSIONS: Intraoperative frozen section examination of the bile duct stump to confirm a clear resection margin is required in patients with mass-forming tumors. Resection of the extrahepatic bile duct should be considered when tumor cells are identified at the surgical margin of the resected bile duct.

Entities:  

Mesh:

Year:  2002        PMID: 12140612     DOI: 10.1007/s005340200024

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  5 in total

1.  Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows.

Authors:  Susan Tsai; Hari Nathan; Timothy M Pawlik
Journal:  Updates Surg       Date:  2010-08

2.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

3.  Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.

Authors:  Chun-Nan Yeh; Ta-Sen Yeh; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

4.  Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.

Authors:  Takayuki Shiraki; Hajime Kuroda; Atsuko Takada; Yoshimasa Nakazato; Keiichi Kubota; Yasuo Imai
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

5.  Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.

Authors:  Shosei Shimizu; Toshiyuki Okumura; Yoshiko Oshiro; Nobuyoshi Fukumitsu; Kuniaki Fukuda; Kazunori Ishige; Naoyuki Hasegawa; Haruko Numajiri; Keiko Murofushi; Kayoko Ohnishi; Masashi Mizumoto; Tetsuo Nonaka; Hitoshi Ishikawa; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2019-12-27       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.